Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer

被引:348
作者
Yang, Da [1 ]
Sun, Yan [1 ,7 ]
Hu, Limei [1 ]
Zheng, Hong [8 ]
Ji, Ping [1 ]
Pecot, Chad V. [6 ]
Zhao, Yanrui [8 ]
Reynolds, Sheila [9 ]
Chen, Hanyin [1 ]
Rupaimoole, Rajesha [2 ]
Cogdell, David [1 ]
Nykter, Matti [10 ]
Broaddus, Russell [1 ]
Rodriguez-Aguayo, Cristian [4 ]
Lopez-Berestein, Gabriel [4 ,5 ]
Liu, Jinsong [1 ]
Shmulevich, Ilya [9 ]
Sood, Anil K. [2 ,3 ,5 ]
Chen, Kexin [8 ]
Zhang, Wei [1 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Noncoding RNA, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[7] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Tianjin 300060, Peoples R China
[8] Tianjin Med Univ Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin 300060, Peoples R China
[9] Inst Syst Biol, Seattle, WA 98103 USA
[10] Tampere Univ Technol, FIN-33101 Tampere, Finland
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
LUNG-CANCER; EPITHELIAL PHENOTYPE; MIR-200; FAMILY; CELLS; GENE; METASTASIS; STATISTICS; TRANSITION; EXPRESSION; CHALLENGES;
D O I
10.1016/j.ccr.2012.12.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Integrated genomic analyses revealed a miRNA-regulatory network that further defined a robust integrated mesenchymal subtype associated with poor overall survival in 459 cases of serous ovarian cancer (OvCa) from The Cancer Genome Atlas and 560 cases from independent cohorts. Eight key miRNAs, including miR-506, miR-141, and miR-200a, were predicted to regulate 89% of the targets in this network. Follow-up functional experiments illustrate that miR-506 augmented E-cadherin expression, inhibited cell migration and invasion, and prevented TGF beta-induced epithelial-mesenchymal transition by targeting SNAI2, a transcriptional repressor of E-cadherin. In human OvCa, miR-506 expression was correlated with decreased SNAI2 and VIM, elevated E-cadherin, and beneficial prognosis. Nanoparticle delivery of miR-506 in orthotopic OvCa mouse models led to E-cadherin induction and reduced tumor growth.
引用
收藏
页码:186 / 199
页数:14
相关论文
共 43 条
  • [1] Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
    Bagga, S
    Bracht, J
    Hunter, S
    Massirer, K
    Holtz, J
    Eachus, R
    Pasquinelli, AE
    [J]. CELL, 2005, 122 (04) : 553 - 563
  • [2] The biology of ovarian cancer: new opportunities for translation
    Bast, Robert C., Jr.
    Hennessy, Bryan
    Mills, Gordon B.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (06) : 415 - 428
  • [3] Integrated genomic analyses of ovarian carcinoma
    Bell, D.
    Berchuck, A.
    Birrer, M.
    Chien, J.
    Cramer, D. W.
    Dao, F.
    Dhir, R.
    DiSaia, P.
    Gabra, H.
    Glenn, P.
    Godwin, A. K.
    Gross, J.
    Hartmann, L.
    Huang, M.
    Huntsman, D. G.
    Iacocca, M.
    Imielinski, M.
    Kalloger, S.
    Karlan, B. Y.
    Levine, D. A.
    Mills, G. B.
    Morrison, C.
    Mutch, D.
    Olvera, N.
    Orsulic, S.
    Park, K.
    Petrelli, N.
    Rabeno, B.
    Rader, J. S.
    Sikic, B. I.
    Smith-McCune, K.
    Sood, A. K.
    Bowtell, D.
    Penny, R.
    Testa, J. R.
    Chang, K.
    Dinh, H. H.
    Drummond, J. A.
    Fowler, G.
    Gunaratne, P.
    Hawes, A. C.
    Kovar, C. L.
    Lewis, L. R.
    Morgan, M. B.
    Newsham, I. F.
    Santibanez, J.
    Reid, J. G.
    Trevino, L. R.
    Wu, Y. -Q.
    Wang, M.
    [J]. NATURE, 2011, 474 (7353) : 609 - 615
  • [4] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [5] Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
    Bentink, Stefan
    Haibe-Kains, Benjamin
    Risch, Thomas
    Fan, Jian-Bing
    Hirsch, Michelle S.
    Holton, Kristina
    Rubio, Renee
    April, Craig
    Chen, Jing
    Wickham-Garcia, Eliza
    Liu, Joyce
    Culhane, Aedin
    Drapkin, Ronny
    Quackenbush, John
    Matulonis, Ursula A.
    [J]. PLOS ONE, 2012, 7 (02):
  • [6] A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
    Bonome, Tomas
    Levine, Douglas A.
    Shih, Joanna
    Randonovich, Mike
    Pise-Masison, Cindy A.
    Bogomolniy, Faina
    Ozbun, Laurent
    Brady, John
    Barrett, J. Carl
    Boyd, Jeff
    Birrer, Michael J.
    [J]. CANCER RESEARCH, 2008, 68 (13) : 5478 - 5486
  • [7] Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
    Cao, L.
    Shao, M.
    Schilder, J.
    Guise, T.
    Mohammad, K. S.
    Matei, D.
    [J]. ONCOGENE, 2012, 31 (20) : 2521 - 2534
  • [8] Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer
    Carvalho, Joana
    van Grieken, Nicole C.
    Pereira, Patricia M.
    Sousa, Sonia
    Tijssen, Marianne
    Buffart, Tineke E.
    Diosdado, Begona
    Grabsch, Heike
    Santos, Manuel A. S.
    Meijer, Gerrit
    Seruca, Raquel
    Carvalho, Beatriz
    Oliveira, Carla
    [J]. JOURNAL OF PATHOLOGY, 2012, 228 (01) : 31 - 44
  • [9] Outcome signature genes in breast cancer: is there a unique set?
    Ein-Dor, L
    Kela, I
    Getz, G
    Givol, D
    Domany, E
    [J]. BIOINFORMATICS, 2005, 21 (02) : 171 - 178
  • [10] The let-7 microRNA reduces tumor growth in mouse models of lung cancer
    Esquela-Kerscher, Aurora
    Trang, Phong
    Wiggins, Jason F.
    Patrawala, Lubna
    Cheng, Angie
    Ford, Lance
    Weidhaas, Joanne B.
    Brown, David
    Bader, Andreas G.
    Slack, Frank J.
    [J]. CELL CYCLE, 2008, 7 (06) : 759 - 764